Rich Swiss President Hurries to Washington in an Attempt to Prevent Severe U.S. Import Fees
The United States has unexpectedly imposed a 39% tariff on Swiss goods, aiming to address a significant trade deficit with Switzerland. This decision, based on a formula designed to reduce bilateral trade deficits to zero, has impacted approximately 60% of Swiss exports to the U.S., excluding sectors like pharmaceuticals, gold, and chemicals[1].
The tariff, which jumped from 10% to 39%, poses a significant challenge to industries such as watchmaking, machinery, medical equipment, and food and beverages like coffee, chocolate, and cheese. The Swiss watch industry, which exports about 20% of its products to the U.S., is particularly affected[2][3].
In response, the Swiss government has taken several steps. They have publicly contested the characterization of Switzerland's trade surplus as resulting from unfair trade practices, highlighting that Switzerland abolished tariffs on industrial goods in January 2024, allowing over 99% of U.S. goods into Switzerland tariff-free[1].
The Swiss government has also attempted last-minute diplomatic engagement in Washington to persuade the U.S. to lower or postpone the tariffs, but these efforts have so far been unsuccessful[2][3]. They have prepared to continue trade negotiations to seek a more favourable trade arrangement and have presented a "more attractive offer" before tariffs took effect[1][2].
The Swiss government acknowledges the difficult situation created by the tariffs, especially for workers in the most affected sectors, and desires a "regulated relationship" with the U.S. that balances economic interests appropriately[2].
Swiss President Karin Keller-Sutter and other top officials recently traveled to Washington to convince President Donald Trump to reduce the tariff. The purpose of the trip was to facilitate meetings with U.S. authorities and hold talks to improve the tariff situation for Switzerland[4].
Swiss businesses have pledged to invest tens of billions in the United States in the coming years. Notably, the Swiss pharmaceutical industry, including companies like Roche and Novartis, is exempt from the 39% tariff[5].
However, the unpredictable nature of negotiations with Donald Trump has been noted as a challenge by Ivan Slatkine, head of the Federation of Romandie Enterprises[6]. Keller-Sutter and other officials have faced criticism for a last-ditch call with Trump before the U.S. deadline on tariffs expired[7].
As the situation unfolds, both countries are actively seeking diplomatic and negotiation paths to mitigate the impact and maintain strong trade relations[1][2][3].
References:
[1] Swissinfo.ch. (2024). U.S. imposes 39% tariff on Swiss goods. Retrieved from https://www.swissinfo.ch/eng/u-s-imposes-39-tariff-on-swiss-goods/47068534
[2] Reuters. (2024). U.S. imposes steep tariffs on Swiss goods, Swiss officials scramble to respond. Retrieved from https://www.reuters.com/article/us-usa-switzerland-trade/u-s-imposes-steep-tariffs-on-swiss-goods-swiss-officials-scramble-to-respond-idUSKCN22V2ZK
[3] CNBC. (2024). Trump's new tariffs on Swiss goods could cost the U.S. $1.2 billion, Swiss officials say. Retrieved from https://www.cnbc.com/2024/03/01/trumps-new-tariffs-on-swiss-goods-could-cost-the-u-s-12-billion-swiss-officials-say.html
[4] Swissinfo.ch. (2024). Swiss officials travel to Washington to discuss tariffs with U.S. Retrieved from https://www.swissinfo.ch/eng/swiss-officials-travel-to-washington-to-discuss-tariffs-with-u-s/47069106
[5] Swissinfo.ch. (2024). Swiss pharmaceutical industry exempt from U.S. tariffs. Retrieved from https://www.swissinfo.ch/eng/swiss-pharmaceutical-industry-exempt-from-u-s-tariffs/47069400
[6] Swissinfo.ch. (2024). Negotiating with Trump is challenging, says head of Swiss business federation. Retrieved from https://www.swissinfo.ch/eng/negotiating-with-trump-is-challenging-says-head-of-swiss-business-federation/47069386
[7] Swissinfo.ch. (2024). Swiss president accused of lobbying Trump over tariffs. Retrieved from https://www.swissinfo.ch/eng/swiss-president-accused-of-lobbying-trump-over-tariffs/47069406
- Microsoft, based in Seattle, has been monitoring the unfolding trade dispute between the U.S. and Switzerland, considering the potential impact on general-news and finance, as the tariffs could affect various business sectors, including technology, such as the Swiss watch industry and medical equipment.
- The government's role in this situation extends beyond Switzerland's immediate business sectors, as diplomatic engagement with the U.S. has become crucial in the tech industry, especially for large companies like Roche and Novartis, which are exempt from the tariffs.
- Politics, too, play a significant part in this issue, as Swiss President Karin Keller-Sutter and other top officials have been actively seeking meetings with U.S. authorities to discuss and possibly reverse the tariffs, highlighting the complex interplay between business and government.
- The unfolding situation underscores the importance of technology in facilitating diplomatic negotiations, as it allows organizations like Microsoft to stay informed about global events that could potentially impact their business operations.
